JPRN-UMIN000010227
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin for HER2-positive operable breast cancer: KBOG-1204 trial - Neoadjuvant TCbH therapy for HER2-positive breast cancer: KBOG-1204 trial
Kanagawa Breast Oncology Group (KBOG)0 sites40 target enrollmentMarch 12, 2013
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kanagawa Breast Oncology Group (KBOG)
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) drug allergy 2\) severe complications (malignant hypertension, congestive heart failure, coronary heart disease, myocardial infarction (onset within 6 months), arrhythmia (treated), infectious disease, bleeding tendency, etc) 3\) feber, infection 4\) peripheral neuropathy 5\) pleural effusion, pericardial effusion 6\) active double cancer 7\) inflammatory breast cancer 8\) bilateral breast cancer, male breast cancer 9\) pregnancy 10\) severe edema 11\) interstitial pneumonia, fibrous lung disease 12\) steroid\-using patients 13\) psychosomatic disease 14\) unsuitable patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaoral squamous cell carcinomaJPRN-C000000023Chubu research group on oral cancer30
Recruiting
Phase 2
Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201JPRN-UMIN000008023The Obstetrical and Gynecological Society of Kinki District Japan and the Kansai Clinical Oncology Group68
Not Yet Recruiting
Phase 2
Phase II multicenter study of neoadjuvant chemotherapy with XELOX for locally advanced rectal cancerJPRN-UMIN000024357Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University35
Not Yet Recruiting
Phase 2
Multicenter phase II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel therapy for patients with resectable pancreatic cancer.Invasive ductal adenocarcinomaJPRN-UMIN000028101Division of Hepato-biliary-pancreatic Surgery Department of Surgery, Kobe University Graduate School of Medicine45
Completed
Phase 2
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000001450Faculty of Medicine, Kyoto University35